Thyroid disease is a favorable prognostic factor in achieving sustained virologic response in chronic hepatitis C undergoing combination therapy: A nested case control study

BACKGROUND: Interferon-α in combination with ribavirin is the current gold standard for treatment of chronic hepatitis C. It is unknown if the development of autoimmune thyroid disease (TD) during treatment confers an improved chance of achieving sustained virologic response. The aim of this study i...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tran, Huy A, Jones, Tracey L, Gibson, Robert, Reeves, Glenn EM
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3123561/
https://ncbi.nlm.nih.gov/pubmed/21605462
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1472-6823-11-10
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares